We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Pyrophosphatase and T7 RNA Polymerase packets.
Product News

Launch of High-Quality Enzymes Suitable for Pre-Clinical and Process Development in mRNA Vaccine

Takara Bio Europe announced the launch of new High Quality grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.
The Gibco CTS Detachable Dynabeads.
Product News

Accelerating Cell Therapies with Manufacturing Breakthrough

Thermo Fisher announced a first of its kind technology to help accelerate the molecule-to-market process by driving efficiency and reducing manufacturing costs.
A scientist pipetting coloured liquid into vials.
Product News

TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration

TherageniX, have been awarded a £995,000 grant from Innovate UK. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery.
An assortment of pills sitting in the palm of a hand.
Product News

Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering

Optibrium, announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades of experience in computational chemistry and biology.
Cell culture in a 12 well plate.
Product News

Polyplus Launches FectoVIR®-LV Transfection Reagent with New DOE Service Options

Polyplus (now part of Satorius), is announcing the pre-order availability of FectoVIR®-LV transfection reagent for lentiviral vector (LV) production.
Vaccine vials.
Product News

NIH and Exothera Collaborate To Produce GMP Intranasal Vaccine Against SARS-CoV-2

The National Institutes of Health selected Exothera S.A. therapeutics to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2.
Next gen sequencing preperation.
Product News

MaxCyte Signs Strategic Platform License With Prime Medicine To Advance Next-Generation Gene Editing Therapies

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), announced the signing of a strategic partnership with Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies.
The Peptide Works kit.
Product News

Waters Corporation Launches PeptideWorks™ Tryptic Protein Digestion Kits

Waters enables automated, high efficiency, and reproducible protein digestion with meaningful sample prep savings.
Artistic illustration of antibodies.
Product News

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

TVM Capital Life Science, together with specialty pharma company, Tillotts Pharma has announced that the companies will jointly invest up to USD 28 million in the newly formed U.S.-based biotechnology company, Mage Biologics Inc.
The cytiva logo
Product News

Cytiva Launches System To Enable End-to-End Manufacturing of Lipid Nanoparticle Medicines

Cytiva has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines.